It has been reported that TFEB may contribute to the development and progression of tumor by upregulating autophagy and endocytosis to meet the metabolic requirement in pancreatic and prostate cancer cells (Perera et al., 2015; Blessing et al., 2017). The gene discussed is TFEB; the disease is neoplasm.